Catheter-based treatments for hepatic metastases from neuroendocrine tumors.
The purpose of this article is to present our experience in treating patients with hepatic metastases from a neuroendocrine primary malignancy. The tumor and patient characteristics, vascular access, and features of treatment all play a role in the long-term management of patients with metatastic neuroendocrine tumors. Routine prophylactic measures are recommended to reduce the frequency and severity of crisis events related to hormone release in patients with neuroendocrine tumors.